| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 254 |
| 1 | INFLIXIMAB | 141 |
| 2 | PREDNISONE | 94 |
| 3 | VEDOLIZUMAB | 92 |
| 4 | UPADACITINIB | 90 |
| 5 | RISANKIZUMAB-RZAA | 87 |
| 6 | USTEKINUMAB | 84 |
| 7 | METHOTREXATE SODIUM | 82 |
| 8 | AZATHIOPRINE | 68 |
| 9 | METHOTREXATE | 66 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 6 | 0.0417 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 7 | 0.0283 |
| 2 | NIACINAMIDE, ZINC GLYCINATE, LEVOMEFOLATE CALCIUM, CUPRIC OXIDE, SELENIUM AND CHROMIUM | 1 | 0.0278 |
| 3 | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | 1 | 0.0109 |
| 4 | INFLIXIMAB-DYYB | 24 | 0.0070 |
| 5 | FERRIC DERISOMALTOSE | 9 | 0.0066 |
| 6 | CLEMASTINE FUMARATE | 9 | 0.0065 |
| 7 | LIDOCAINE, PRILOCAINE | 1 | 0.0050 |
| 8 | AAMLODIPINE AND OLMESARTAN MEDOXOMIL | 1 | 0.0049 |
| 9 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 193 |
| 1 | Interleukin-23 Antagonist [EPC] | 172 |
| 2 | Corticosteroid [EPC] | 140 |
| 3 | Integrin Receptor Antagonist [EPC] | 92 |
| 4 | Janus Kinase Inhibitor [EPC] | 90 |
| 5 | Interleukin-12 Antagonist [EPC] | 84 |
| 6 | Purine Antimetabolite [EPC] | 68 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 66 |
| 8 | Aminosalicylate [EPC] | 48 |
| 9 | Vitamin B12 [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 1 | Interleukin-23 Antagonist [EPC] | 172 | 0.0016 |
| 2 | Bile Acid Sequestrant [EPC] | 15 | 0.0012 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Integrin Receptor Antagonist [EPC] | 92 | 0.0011 |
| 5 | Interleukin-12 Antagonist [EPC] | 84 | 0.0008 |
| 6 | Provitamin D2 Compound [EPC] | 24 | 0.0008 |
| 7 | GLP-2 Analog [EPC] | 10 | 0.0007 |
| 8 | Interferon gamma [EPC] | 1 | 0.0007 |
| 9 | Allylamine Antifungal [EPC] | 5 | 0.0007 |